Federal award (DELIVERY ORDER, fiscal year 2024)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2025-04-30 to 2025-05-12
Current total value of award: $1482
Description: 8511351288!TYPHOID VI POLYSACC